Search

Neostigmine Injection – Uses, 0.5 mg/ml & Product Details

  • Generic Name: Neostigmine Methylsulfate
  • Product: Neostigmine Injection IP
  • Strength: 0.5 mg/ml
  • Dosage Form: Injection
  • Pack Size: 10 ampoules of 1 ml
  • Ampoule Volume: 1 ml
  • Route: IM, SC or Slow IV injection
  • Category: Prescription Injectable
  • Supply: Hospital, institutional and bulk supply enquiries

Neostigmine Injection is a prescription injectable formulation containing Neostigmine Methylsulfate. The supplied presentation contains 0.5 mg/ml of neostigmine Methylsulfate and is available in 1 ml ampoules, with a pack presentation of 10 ampoules.

Neostigmine Injection is used in selected clinical situations under the direction of a qualified healthcare professional. The supplied product is labelled for IM, SC or Slow IV injection.

Scotmed Care supports pharmaceutical product enquiries for hospitals, healthcare institutions and eligible pharmaceutical distributors. For buyers looking for injectable pharmaceutical products, our injectable pharmaceutical portfolio provides additional product information.

What Is Neostigmine Injection?

Neostigmine Injection is an injectable formulation of neostigmine Methylsulfate, a reversible acetylcholinesterase inhibitor.

Neostigmine increases the availability of acetylcholine at relevant neuromuscular and cholinergic sites. Its clinical effects can therefore be useful in specific medical situations where enhancement of cholinergic activity is indicated.

The injection should only be administered by a qualified healthcare professional according to the approved prescribing information and the patient’s clinical requirements.

Neostigmine Injection Composition

The supplied product packaging specifies the following composition:

Product Detail Information
Active ingredient Neostigmine Methylsulfate
Strength 0.5 mg/ml
Ampoule volume 1 ml
Dosage form Injection
Pack presentation 10 × 1 ml ampoules
Administration IM, SC or Slow IV injection

Each 1 ml ampoule contains Neostigmine Methylsulfate 0.5 mg with water for injection as the vehicle.

The current product label and approved prescribing information should always be checked before administration.

Neostigmine Injection 0.5 mg/ml

Neostigmine Injection 0.5 mg/ml is supplied in a 1 ml ampoule. The displayed pack contains 10 ampoules of 1 ml.

The product is labelled for:

  • Intramuscular administration
  • Subcutaneous administration
  • Slow intravenous administration

The appropriate route and dose depend on the clinical indication and should be determined by the treating healthcare professional.

Neostigmine Injection Uses

Neostigmine Injection uses are associated with its pharmacological action as a reversible acetylcholinesterase inhibitor.

Depending on the approved indication and clinical circumstances, neostigmine may be used in situations such as:

  • Reversal of the effects of certain non-depolarizing neuromuscular blocking agents
  • Selected situations involving reduced gastrointestinal motility where neostigmine therapy is medically indicated
  • Selected conditions involving impaired bladder or intestinal function, according to approved clinical indications

The specific use, dosage and administration route must be determined by a qualified healthcare professional.

Neostigmine should not be used for self-treatment.

For additional critical-care pharmaceutical information, explore our critical-care pharmaceutical portfolio.

How Does Neostigmine Injection Work?

Neostigmine inhibits the enzyme acetylcholinesterase, which normally breaks down acetylcholine.

By reducing the breakdown of acetylcholine, neostigmine increases acetylcholine activity at relevant sites in the body. This mechanism contributes to its effects on neuromuscular transmission and certain smooth-muscle functions.

The clinical response depends on the indication, dose, route of administration and individual patient factors.

Administration of Inj Neostigmine

Inj Neostigmine should be administered only by a qualified healthcare professional.

The supplied product is labelled for IM, SC or Slow IV injection.

The healthcare professional should determine:

  • Appropriate dose
  • Route of administration
  • Administration rate
  • Treatment duration
  • Need for patient monitoring

Slow IV administration should be performed according to approved prescribing information and appropriate clinical protocols.

Patients should not self-administer Neostigmine Injection.

Important Precautions

Neostigmine can produce significant cholinergic effects. Appropriate patient assessment and monitoring are important during treatment.

Healthcare professionals should consider the patient’s medical history, concurrent medicines and relevant contraindications before administration.

Possible cholinergic effects may include increased salivation, sweating, abdominal symptoms, changes in heart rate and other effects related to increased acetylcholine activity.

The product should be administered only under medical supervision.

The supplied packaging states:

  • Store below 30°C
  • Protect from light
  • Keep the medicine out of reach of children
  • Do not use if suspended particles are observed
  • The product should not be used in newly born or premature infants as stated on the supplied packaging

Always consult the current approved prescribing information for complete contraindications, warnings, precautions, interactions and adverse effects.

Neostigmine Injection for Hospital and Institutional Supply

Neostigmine Injection is relevant to hospital and institutional pharmaceutical procurement where injectable cholinesterase inhibitor products are required.

Scotmed Care supports B2B enquiries from hospitals, healthcare institutions and eligible pharmaceutical distributors.

For supply enquiries, buyers can provide:

  • Organisation or hospital name
  • Required quantity
  • Required pack presentation
  • Delivery location
  • Procurement requirements

This allows the team to provide relevant product availability and supply information.

For more pharmaceutical product options, visit the Scotmed Care pharmaceutical range.

Frequently Asked Questions About Neostigmine Injection

1. What is Neostigmine Injection?

Neostigmine Injection is a prescription injectable formulation containing Neostigmine Methylsulfate. It is used in selected clinical situations under qualified medical supervision.

2. What is the strength of Neostigmine Injection?

The supplied product contains Neostigmine Methylsulfate 0.5 mg/ml.

3. What is the ampoule size?

The supplied presentation contains 1 ml per ampoule, with 10 ampoules in the displayed pack.

4. What are the uses of Neostigmine Injection?

Neostigmine Injection may be used for selected indications including reversal of certain non-depolarizing neuromuscular blocking effects and other approved clinical uses involving cholinergic activity.

5. What is Inj Neostigmine?

Inj Neostigmine is a commonly used abbreviated term for Neostigmine Injection.

6. What is the route of administration?

The supplied packaging specifies IM, SC or Slow IV injection.

7. Can Neostigmine Injection be self-administered?

No. It is a prescription injectable and should be administered by a qualified healthcare professional according to the approved prescribing information.

8. How should Neostigmine Injection be stored?

The supplied packaging states that the product should be stored below 30°C and protected from light. Always follow the current product label for storage requirements.

Enquire About Neostigmine Injection

Hospitals, healthcare institutions and eligible pharmaceutical distributors can contact Scotmed Care for product availability and institutional supply enquiries regarding Neostigmine Injection 0.5 mg/ml.

Scotmed Care Pvt. Ltd.

Eligible buyers can share their required quantity, organization details and delivery location for relevant product and supply information.

Medical Disclaimer: This page is intended for general product information and procurement reference only. Neostigmine Injection is a prescription medicine and should be administered only by qualified healthcare professionals. Refer to the current approved prescribing information and product label for complete details.

Content missing

Scroll to Top